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     INTRODUCTION 
  Dengue is the most widely distributed mosquito-borne viral 
infection of humans, affecting up to 100 million persons each 
year across the tropical world.  1,  2   Infection with any of the four 
dengue viral serotypes may result in asymptomatic infection 
or may cause a range of disease manifestations from non-spe-
cific fever to a syndrome characterized by increased vascular 
permeability, thrombocytopenia, and deranged hemostasis. In 
severe cases, the increased vascular permeability results in cir-
culatory compromise and the patient may develop potentially 
life-threatening dengue shock syndrome (DSS).  2–  4   No specific 
antiviral therapy is available but the physiologic derangements 
are transient, and most patients recover fully if supported with 
parenteral fluid therapy during the period of maximal vascular 
leakage. Current mortality rates for DSS are less than 1% in 
experienced hands.  5–  7  
  Dengue shock syndrome is an important cause of hospi-
talization among children living in dengue-endemic areas. 
However, in general, severe bleeding is not a major problem 
in this group, despite often profound thrombocytopenia and 
clear evidence of a coagulopathy.  8–  10   In recent years, there has 
been a notable increase in the number of adults with den-
gue requiring hospitalization in Asia and South America.  6,  11,  12  
Dengue shock syndrome appears to be less frequent in adults 
than children, possibly reflecting age-dependent differences in 
intrinsic vascular permeability, but there is anecdotal evidence 
to suggest that bleeding manifestations and hepatic dysfunc-
tion are both more common in older age groups.  6,  11,  13   There 
have been few prospective studies focused on disease manifes-
tations in adults, and there is little systematic data describing 
the clinical profile of disease in older patients or those with co-
morbidities, or detailing the evolution of clinical and labora-
tory parameters through the various stages of the infection. 
  Hepatic dysfunction is a well recognized feature of dengue 
infections, often demonstrated by hepatomegaly and mild-to-
moderate increases in transaminase levels although jaundice 
and acute liver failure are generally uncommon.  14–  17   Biopsy 
specimens obtained from a small number of patients with DSS 
who died have shown a variety of patterns including microve-
sicular steatosis, hepatocellular necrosis with associated coun-
cilman bodies, Kupffer cell destruction, and inflammatory 
infiltrates at the hepatic portal tracts.  18,  19   Dengue antigens 
and viral RNA have been demonstrated in some of these fatal 
cases, and dengue viruses have been isolated occasionally 
from hepatic tissue.  19–  22   However, biopsy specimens are rarely 
obtained from less severe cases and the relevance of these 
findings to the broad spectrum of dengue infections remains 
uncertain. Debate continues as to whether dengue associated 
hepatic dysfunction indicates a direct viral effect, arises sec-
ondary to an aggressive host immune response to the virus, or 
reflects a complex interaction of these two mechanisms. 
  One factor that may influence the pattern of disease seen 
in adults is the greater likelihood of underlying chronic dis-
eases, potentially compounding the effects of the acute infec-
tion. Chronic viral hepatitis is common among adults in many 
tropical and sub-tropical countries where dengue is endemic, 
and it has been postulated that dengue infection occurring 
on a background of chronic infection with hepatitis B virus 
(HBV) or hepatitis C virus (HCV) may result in more severe 
liver dysfunction and/or hemorrhage than is usual in non-
infected persons. However, the evidence to date is conflicting; 
two small studies indicated no effect,  14,  15   and one study sug-
gested that concomitant HBV infection may result in greater 
hepatic dysfunction.  23  
  We conducted a large prospective study to describe the 
spectrum of symptomatic dengue disease among adults admit-
ted to a major infectious disease hospital in southern Vietnam. 
We focused particularly on liver involvement, aiming to assess 
relationships with vascular leakage and bleeding manifesta-
tions. We also examined the question of whether concomitant 
infection with HBV or HCV influenced the overall severity of 
the clinical picture. 
   METHODS 
    Patients and clinical methods.     Patients more than 14 years 
of age admitted to the Hospital for Tropical Diseases in Ho 
Chi Minh City, Vietnam, with clinically suspected dengue were 
eligible for enrollment in the study after written informed 
consent was obtained from a patient or a relative in the case 
of those with coma or very severe disease. Ethical approval 
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was obtained from the Scientific and Ethical Committee of 
the Hospital for Tropical Diseases and the Oxford University 
Tropical Research Ethics Committee, United Kingdom. The 
hospital admits approximately 5,000 adults with dengue 
each year. Recruitment was targeted to include all patients 
with suspected dengue admitted to the Adult Intensive Care 
Unit (AICU) plus a group of 200 female patients and 200 
male patients with suspected dengue admitted to particular 
infectious disease wards. 
  Within 24 hours of admission, designated senior doctors on 
these wards tried to recruit all patients admitted to specific 
bays with suspected dengue; diagnostic criteria were not speci-
fied because we aimed to include the full spectrum of hospi-
talized cases. Detailed clinical information was collected daily 
for the duration of the hospital stay by one study physician 
by using a standard case report form particularly focused on 
liver involvement, bleeding manifestations, and evidence of 
vascular leakage. A venous blood sample was obtained each 
day for clinical and diagnostic investigations as detailed below. 
Additional investigations and management were at the discre-
tion of the treating physicians. Patients in whom complications 
developed were transferred from the infectious disease wards 
to the AICU and continued with daily clinical assessment by 
the same study physician. After discharge all patients were 
invited to attend for review approximately one month after 
the illness onset. 
  Acute liver failure was diagnosed in patients without evi-
dence of pre-existing cirrhosis in whom any degree of men-
tal alteration with increased liver enzyme levels and a 
coagulopathy (as demonstrated by an international normal-
ized ratio ≥ 1.5) developed.  24   Following the new World Health 
Organization guidelines, vascular leakage was classified pri-
marily according to whether hypovolemic shock developed 
in the patient.  4   We defined shock as hypotension or narrow-
ing of the pulse pressure with impaired peripheral perfusion 
that was thought to be caused by plasma leakage, not bleeding, 
and required volume resuscitation. We also classified the den-
gue patients without shock into two categories: those with and 
without clear evidence of vascular leakage. 
  Criteria for inclusion in the vascular leakage without shock 
group were either hemoconcentration ≥ 20% between the 
peak recorded hematocrit and a baseline value obtained 
before day 3 of illness or the local population mean for age 
and sex (reference database for 850 healthy adults in Vietnam, 
unpublished data), and/or evidence of fluid accumulation on 
a radiograph or ultrasound image obtained at the time of 
defervescence. Patients without hemoconcentration who had 
more than three days of serial hematocrit data and a properly 
timed negative radiograph/ultrasound image were classified 
as having dengue without evidence of vascular leakage, and 
patients with insufficient data were considered unclassifiable. 
The severity of bleeding manifestations was also coded retro-
spectively into one of the following four categories: no clini-
cal bleeding detected, minor skin bleeding only (petechiae or 
bruising at venipuncture sites), minor mucosal bleeding with 
or without minor skin bleeding, and severe bleeding defined 
as any bleeding requiring an intervention or any bleeding into 
vital organs (e.g., intracranial bleeding). 
   Laboratory  methods.     A complete blood count was obtained 
at least once a day in the routine hematology laboratory. On 
AICU hematocrit measurements were also made as frequently 
as required for clinical management. Albumin, bilirubin, and 
transaminase levels were determined at intervals during the 
course of disease: the early febrile period (days 1–3 of illness), 
the critical period for complications such as shock (days 4–6), 
and the convalescent period (days 7–10). We also performed 
coagulation screening tests for the first 200 patients at these 
time points, as well as for any patient with a clinical indication. 
Plasma was separated and stored at –80°C within six hours of 
sampling for subsequent analysis in batches in a specialized 
hematology laboratory. All tests were repeated at the follow-
up visit. 
  Diagnostic tests for HBV and HCV were performed on 
stored convalescent-phase or follow-up samples by using 
AxSYM reagents (Abbott, Abbott Park, IL). Antibodies to 
hepatitis B core protein (HBc) were measured in an initial 
screen in all patients, and tests for hepatitis B surface antigen 
and IgM against HBc were performed if the first antibody test 
result was positive. Antibodies to HCV were measured in sam-
ples from the first 200 patients enrolled in the study. 
  For diagnosis of dengue, IgM- and IgG-capture enzyme-
linked immunosorbent assays were performed for paired 
specimens. A dengue virus polymerase chain reaction and a 
nonstructural protein 1 enzyme-linked immunosorbent assay 
were also conducted for the first specimen if obtained within 
the first five days of illness, or if serologic results were nega-
tive or inconclusive. The techniques used and interpretation 
of results were performed as reported.  25   Patients in whom all 
dengue diagnostic results were conclusively negative, in whom 
there was no evidence of any other infectious disease, and who 
recovered without antibiotic therapy, were considered to have 
had other febrile illnesses (OFIs). 
   Statistical  analysis.     Data for clinical characteristics and 
laboratory results were compared between different patient 
groups by using the chi-square test or Fisher’s exact test 
for categorical variables and the Mann-Whitney test or the 
Cuzick test for trend for continuous variables. Within-patient 
comparisons of different parameters or of the same parameter 
measured at different time points were performed by using the 
Wilcoxon signed-rank test. Spearman’s rank correlation was 
used to evaluate relationships between continuous variables 
assessed concurrently. All statistical computations were carried 
out using SPSS version 14 (SPSS, Inc., Chicago, IL) and Stata 
SE Version 8 (StataCorp., College Station, TX). 
    RESULTS 
  During September 2006–September 2008, 740 persons 
were recruited into the study, including 340 enrolled in AICU 
(90% of those eligible) plus 200 male and 200 female patients 
(approximately 50% of those eligible from the designated 
bays on the relevant infectious disease wards). Dengue was 
confirmed in 644 (87%) of 740 patients and 47 patients (6%) 
were classified as having OFIs. The infecting serotype was 
identified in 207 (32%) patients: dengue 1 virus in 108 patients, 
dengue 2 virus in 65 patients, dengue 3 virus in 30 patients, 
and dengue 4 virus in 4 patients. An alternative diagnosis 
(e.g., malaria, bacterial sepsis) was confirmed or suspected in 
13 patients (2%), all of whom had negative dengue diagnos-
tic      results. In the remaining 36 patients (5%), the results of 
serologic and virologic diagnostic tests were inconclusive. 
  Among the 644 patients with confirmed dengue, 55 (9%) 
were admitted first to one of the infectious disease wards but 
transferred to the AICU during their hospital stay. Six patients 776 TRUNG AND OTHERS
with dengue died, one patient without shock died of acute liver 
failure, and complications including severe bleeding, enceph-
alopathy, renal failure and/or metabolic acidosis developed in 
five patients with shock; they died despite supportive care. The 
other patients in the study fully recovered and 296 (40%) of 
the survivors attended follow-up. The remainder of this report 
focuses on patients with confirmed dengue or OFIs. 
  Demographic and summary clinical data are shown in 
  Table 1  . Although dengue and patients with OFIs were of 
similar age, dengue patients with shock were slightly younger 
than those without shock and presented approximately one 
day later in the evolution of their illness. Shock did not occur 
in the OFI group, and there were few bleeding or hepatic 
manifestations, although 5 of 47 were admitted briefly to the 
AICU for observation during the critical period for shock. All 
the 112 dengue patients with shock manifested some evidence 
of clinical bleeding, including a mucosal site in more than 70% 
of the patients. However, among the 55 dengue patients who 
experienced severe bleeding, most (40 patients, 73%) did not 
have shock. 
            In this group, one patient had intracranial bleeding con-
firmed by computed tomography scan, 26 required transfusion 
of blood products for major mucosal bleeding (19 erythrocyte 
transfusions and 7 fresh-frozen plasma and/or platelet trans-
fusions), and 13 required nasal packing for severe epistaxis. 
Thrombocytopenia (thrombocyte count ≤ 100 × 10  9 /L)  was 
seen in 614 (95%) of 644 dengue patients. Thrombocyte min-
imum values (median and 90% range) were similar in the 
patients with shock (17, 9–46 × 10  9  /L) and in the group with 
severe bleeding without shock (21, 2–83 × 10  9  /L), and were 
lower than the minimum values seen in patients without shock 
or severe bleeding (33, 9–113 × 10  9 /L)  ( P   < 0.001, by Mann-
Whitney test). Among the 160 patients with confirmed dengue 
for whom serial coagulation screening tests were performed, 
the pattern was of significantly increased activated partial 
thromboplastin times (APTT), reduced fibrinogen levels, and 
relatively normal prothombin time (PT) measurements simi-
lar to the values seen in the OFI group (  Table 1  ). 
  Abdominal pain and hepatomegaly were seen more com-
monly in patients with shock than in those without shock 
(  P   < 0.001, by chi-square test) (  Table 1  ). Visible jaundice was 
noted in only 11 (< 2%) of 644 dengue patients, of whom 
8 had severe bleeding. Acute liver failure developed and 
markedly deranged coagulation test results were observed for 
five of these patients, none of whom had shock; one patient 
died. Jaundice appeared relatively late, commonly during the 
second week of illness several days after the expected time 
for shock (median [range]) day of onset (7 days [6–12 days]) 
and was minor in all cases except those with acute liver failure. 
The infecting serotype (dengue 2 virus) was identified in only 
one case with jaundice. Information on ingestion of potentially 
hepatotoxic medications was limited because most patients did 
not know what medications they had been prescribed before 
hospital admission. However, more than 90% of the patients 
in the study admitted taking standard doses of paracetamol 
for symptomatic relief, with the pattern of ingestion similar in 
those with and without severe liver involvement. Although we 
attempted to gather information on prior alcohol consump-
tion, the response rate was poor and the data collected were 
believed to be unreliable, precluding analysis. 
    Changes in liver function test results.    Bilirubin  levels 
fell within the normal range for almost all patients except 
 T able  1 
    Demographic, summary clinical information, and coagulation tests results for adults with confirmed dengue infection (with and without shock) 
and those with other febrile illnesses  *     
Characteristic Other febrile illness (n = 47)
Confirmed dengue (n = 644)
No shock (n = 532) Shock (n = 112)   P  †  
Age, years 21 (16–49) 22 (15–35) 20 (15–32) 0.02
Male sex 21 (45) 268 (50) 49 (44) 0.20
Day of illness on enrollment 4 (2–6) 5 (3–7) 6 (4–7) < 0.001
Any skin bleeding  ‡  16 (34) 445 (84) 109 (98) < 0.001
Any mucosal bleeding  ‡  15 (32) 293 (55) 80 (72) < 0.001
Bleeding severity  ‡ 
No bleeding 24 (51) 54 (10) 0 –
Skin bleeding only 8 (17) 185 (35) 30 (27) 0.12
Minor mucosal bleeding with or 
without skin bleeding 15 (32) 253 (48) 66 (60) 0.02
Severe bleeding, any site 0 40 (8) 15 (14) 0.04
Abdominal pain  §  20 (43) 303 (58) 93 (85) < 0.001
Liver palpable  ¶  5 (11) 141 (27) 83 (74) < 0.001
Liver enlarged > 2 cm  ¶    #  0 15 (3) 13 (12) 0.27
Jaundice 0 9 (2) 2 (2) 0.94
Acute liver failure  **  0 5 (1) 0 –
Hospital stay, days 5 (4–7) 5 (2–8) 5 (2–12) 0.25
Death ††  0 1  (< 1) 5 (5) –
Lowest platelet count × 10  9  /L 103 (36–170) 32 (9–111) 17 (9–46) < 0.001
Highest PT value,  ‡‡   seconds 16.6 (14.9–20.5) 16.1 (13.3–20.2) 16.7 (14.5–27) 0.03
Highest APTT value,  ‡‡   seconds 38.1 (32–56.4) 45.3 (33.9–62.7) 50.5 (38.8–120) < 0.001
Lowest fibrinogen level,  ‡‡   g/L 3.8 (2.2–4.9) 2.8 (1.7–3.9) 2.1 (0.5–3.8) < 0.001
    *     Values are no. (%) for categorical variables and median (90% range) for continuous variables. PT = prothrombin time; APTT = activated partial thromboplastin time.   
  †     P   value for comparisons between confirmed dengue infection with and without shock.   
    ‡     Missing data for one patient in confirmed dengue infection group with shock.   
    §     Missing data for 9 and 2 patients in confirmed dengue infection groups without and with shock, respectively.   
    ¶     Missing data for one patient in confirmed dengue infection without shock.   
  #   Liver  palpable  > 2 cm below the costal margin in the mid-clavicular line.   
    **     Development of any degree of mental alteration with elevated liver enzyme levels and an international normalized ratio ≥ 1.5 in a patient without evidence of pre-existing cirrhosis.   
    ††     Causes of death: 1 acute liver failure, 1 shock plus encephalopathy, 2 shock plus severe bleeding, 1 prolonged shock, and 1 shock with multi-organ failure.   
    ‡‡     No. patients with results for coagulation screening tests for other febrile illness, no shock, and shock groups are 20, 122, and 38, respectively.   777 LIVER INVOLVEMENT IN ADULTS WITH DENGUE
those with visible jaundice. Serial transaminase levels are 
shown in   Figure 1   and   Table 2   according to the severity of 
vascular leakage or bleeding and grouped according to timing 
during the evolution of the illness. When we considered all 
dengue patients, only 22 (3%) of 644 had normal aspartate 
aminotransferase (AST) and alanine aminotransferase (ALT) 
levels (≤ 40 IU/L) throughout the course of their illness, 
compared with 23 (49%) of 47 of the OFI patients. In the 
dengue group, AST and ALT levels began to increase slightly 
in the early febrile period: median (90% range) of 43 IU/L 
(18–314 IU/L) for AST levels and 40 IU/L (14–236 IU/L) for 
ALT levels compared with 24 IU/L (13–68 IU/L) for AST 
levels and 32 IU/L (13–101 IU/L) for ALT levels at follow-up 
(  P   < 0.001 for AST and   P   = 0.02 for ALT, by Wilcoxon signed-
rank test). Both enzyme levels increased significantly in the 
critical period to 107 IU/L (30–483 IU/L) for AST and 83 IU/L 
(22–422 IU/L) for ALT, and reached peak concentrations 
of 138 IU/L (45–547 IU/L) for AST and 136 IU/L (31–
574 IU/L) for ALT during the convalescent period (  P   < 0.001 
for comparisons of critical and convalescent values with 
followup values and   P   < 0.01 for comparisons of critical values 
with convalescent values, by Wilcoxon signed-rank test). 
              The highest enzyme levels were recorded in patients with 
jaundice (median [90% range] of 1,663 IU/L [320–8,680 
IU/L] for maximum AST levels during the disease course 
and 971 IU/L [334–9,917 IU/L] for maximum ALT levels). 
Levels had returned to the expected normal range at the one 
month followup visit in 203 (88%) of 231 dengue patients for 
AST and in 145 (63%) of 231 dengue patients for ALT. The 
ALT levels were significantly higher than AST levels in OFI 
patients in the critical and convalescent periods (  P   < 0.05, 
by Wilcoxon signed-rank test). In contrast, AST levels were 
consistently higher than ALT levels in the critical and con-
valescent periods in dengue patients (  P   < 0.01, by Wilcoxon 
signed-rank test). 
 In terms of correlation between transaminase levels and mark-
ers of disease severity, during the critical period, AST and ALT 
levels were significantly higher in the dengue patients who expe-
rienced shock compared with those without shock (  P   < 0.01, by 
Mann-Whitney test). This association was still apparent during 
 F igure   1.        Box and whisker plots showing serial measurements of A, aspartate aminotransferase (AST) and B, alanine aminotransferase (ALT) 
levels in adults with confirmed dengue infection shown in groups according to the overall severity of vascular leakage and with results for the group 
with other febrile illnesses (OFI). Total number of patients included in each group is indicated. Forty-six of 644 dengue patients could not be clas-
sified for vascular leakage severity because of missing information and are not included. Cuzick test for trend was used to compare transaminase 
levels in each period across the three vascular leakage severity categories within the dengue patient group, ***   P   < 0.001 and **   P   < 0.01. Boxes 
represent the median and interquartile values. Open circles indicate outlying values but extremes are not shown.       
 T able  2 
    Transaminase levels according to the severity of bleeding in adults with confirmed dengue infection and in the other febrile illness  group *   
 
AST (U/L) ALT (U/L)
D1–3 D4–6 †  D7–10 †  FU D1–3 D4–6 †  D7–10 †  FU
Other illness group (n = 47) 
(n = 23, 45, 24, 15)  ‡ 
26 29 44 20 24 31 54 30
13–105 12–247 23–553 11–65 8–127 16–257 24–575 11–102
Confirmed dengue (n = 644)
No bleeding 
(n = 15, 50, 31, 9)  ‡ 
42 58 108 24 29 46 93 26
18–141 23–324 30–239 17–33 7–115 17–250 23–270 18–47
Skin bleeding only 
(n = 35, 205, 154, 70)  ‡ 
47 104 123 23 43 78 109 30
20–316 34–359 47–449 13–58 17–371 25–354 36–448 12–102
Minor mucosal bleeding 
(n = 41, 289, 255, 124)  ‡ 
41 117 151 25 39 98 151 37
14–185 30–527 46–539 13–78 13–209 23–428 31–553 14–128
Severe bleeding 
(n = 4, 38, 45, 28)   ‡ 
322 136 184 24 166 140 148 28
51–1,008 25–2,546 34–4,520 12–72 47–251 26–2,816 20–4,045 12–100
    *     Values are median and 90% range. AST = aspartate aminotransferase; ALT = alanine aminotransferase; D = day; FU = followup.  
    †     Cuzick test for trend was used to compare transaminase levels across the four bleeding severity categories within the dengue patient group (  P   < 0.001).   
    ‡     No. of patients in early febrile (D1–3), critical (D4–6), convalescent (D7–10) periods and at follow-up, respectively.   778 TRUNG AND OTHERS
the convalescent period for AST (  P   < 0.05, by Mann-Whitney 
test), but ALT levels were similar in the two groups at this time. 
A similar pattern was observed when we examined associa-
tions between transaminase levels and the more detailed grad-
ing of vascular leakage severity, excluding the 46 patients who 
could not be classified due to lack of information (Figure 1). In 
addition, the AST and ALT levels for dengue patients corre-
lated significantly with bleeding severity in the critical and con-
valescent periods ( P  < 0.001, by Cuzick test for trend) ( Table 2 ). 
Both liver enzyme levels demonstrated weak negative correla-
tions with the lowest thrombocyte count and plasma fibrinogen 
level recorded during the same period (Spearman correla-
tions  = –0.2 to –0.3; all   P   < 0.05) and weak positive correlations 
with the APTT (Spearman correlations = 0.2–0.3; all   P   < 0.05) 
in the critical and convalescent periods. The PT showed a weak 
association with transaminase levels only in the convalescent 
period (Spearman correlation = 0.2; both   P   < 0.05). 
      Effect of chronic HBV or HCV co-infection on bleeding 
severity and laboratory results.     Serologic results for antibodies 
to HCV were positive in only 3 (2 dengue patients and 1 OFI 
patient) of the 208 patients tested. Evidence for prior exposure 
to HBV (antibodies to HBc) was found in 344 (50%) of 694 
patients tested, and evidence for chronic HBV infection 
(antibodies to HBc with positive results for hepatitis B surface 
antigen and negative results for IgM to HBc) was detected in 69 
(11%) of 618 dengue patients and 9 (19%) of 47 OFI patients. 
Acute HBV infection (IgM to HBc) was not found in any patient. 
In the dengue group, ALT levels in the critical period were 
modestly but significantly higher in patients with chronic HBV 
co-infection than in patients without co-infection (  P   = 0.001, 
by Mann-Whitney test). A small increase in AST levels was 
also observed in the critical period but this was not statistically 
significant. No association was demonstrated between AST or 
ALT levels and HBV co-infection by the convalescent period 
(  Table 3  ). In addition, HBV infection had no effect on bleeding 
severity, vascular leakage severity or development of shock, 
severity of thrombocytopenia, or on any of the coagulation 
screening tests in the dengue patients. Infection with HBV was 
noted in only one of the eleven patients with jaundice and in 
none of those with acute liver failure. 
         DISCUSSION 
  This prospective observational study presents a detailed 
description of the evolution of the clinical manifestations of 
dengue in a large group of adults admitted to an infectious 
disease hospital in southern Vietnam. Because the Hospital 
for Tropical Diseases is a referral hospital and recruitment 
was focused on patients admitted to the AICU, findings gen-
erally represent the more severe end of the disease spectrum. 
However, 546 (74%) of 740 patients enrolled in the study went 
directly to the hospital. The main finding was that mild-to-mod-
erate hepatic dysfunction, assessed by serial measurements of 
liver enzyme levels, was apparent in almost all dengue patients 
and correlated with other measures of severity, although the 
most abnormal results were noted rather later than during the 
generally accepted critical period for other complications. 
  Transaminase levels began to increase from an early stage 
(day 1–3 of illness) and peaked during the second week of ill-
ness. Severe liver involvement (acute liver failure and/or jaun-
dice) was rare, but also commonly occurred during the second 
week of illness. By follow-up, AST levels had returned to nor-
mal levels in most patients, but ALT levels remained slightly 
increased above the normal range in approximately one-third 
of the patients. This general pattern, with AST increasing more 
quickly and peaking at a higher level and then reverting to 
normal sooner than ALT levels, is unusual and differs from 
that commonly seen during acute hepatitis caused by hepatitis 
viruses,  26   but is similar to observations in studies of dengue in 
children and adults.  14–  16   In addition, the effect of chronic HBV 
co-infection was primarily apparent on ALT levels. 
  Although these results indicate that most adults with den-
gue infection have some degree of hepatic involvement, an 
additional non-hepatic source of AST could explain the pat-
tern observed. Alanine aminotransferase is primarily associ-
ated with hepatocytes, with minimal activity in cardiac and 
skeletal muscle, and AST is found in erythrocytes, cardiac and 
skeletal muscle, and kidney and brain tissue, and is often ele-
vated because of damage to those sources and in response to 
hepatic damage.  26   Given the prominence of musculoskeletal 
symptoms among adults with dengue, skeletal muscle injury 
could contribute to the elevation in AST levels. The plasma 
half-life of AST is shorter than that of ALT,  26   but it is possi-
ble that the slower improvement in ALT levels simply reflects 
slower evolution of the hepatic disease than of the musculosk-
eletal problems. We were unable to investigate specific muscle 
enzymes or isoforms in this study, but creatine kinase levels 
are known to be elevated during the acute phase of dengue 
infection.  27   In combination with other simple laboratory tests, 
transaminase levels, particularly AST levels, have been sug-
gested as a potential marker to help differentiate dengue from 
other viral infections during the early febrile phase.  28  However, 
mild-to-moderate increases in transaminase levels, with AST 
higher than ALT levels, are a non-specific finding that may be 
observed in a number of other infections such as typhoid fever 
and malaria  29,  30   and in alcohol-related hepatitis.  26  
  In agreement with results of smaller studies, we found asso-
ciations between transaminase levels and increasing sever-
ity of vascular leakage and bleeding severity.  14–  17   Acute  liver 
failure developed in only a small number of patients, none of 
whom had severe vascular leakage. In addition, severe bleed-
ing (requiring intervention or involving a vital organ) was 
seen in 55 (9%) of 644 dengue-infected adults, most of whom 
did not have shock. This finding is in contrast to our previous 
pediatric studies at the same hospital, in which severe bleeding 
was much less frequent and was almost invariably associated 
with DSS and prolonged shock.  8,  10   Although liver involvement 
 T able  3 
    Effect of chronic hepatitis B virus co-infection on bleeding severity 
and transaminase levels in 618 adults with dengue  *     
Characteristic
Chronic HBV 
co-infection (n = 69)
No evidence for HBV 
infection (n = 549)   P  †  
Severe bleeding 7 (10) 44 (8) 0.55
Mucosal bleeding or any 
severe bleeding 46 (67) 312 (57) 0.12
AST in critical period  ‡  122 (28–548) 105 (30–483) 0.07
ALT in critical period  ‡  118 (29–520) 81 (22–385) 0.001
AST in convalescent period  §  152 (58–443) 137 (41–563) 0.68
ALT in convalescent period  §  144 (50–637) 135 (30–581) 0.21
    *      Values are no. (%) for categorical variables and median (90% range) for continuous 
variables. HBV = hepatitis B virus; AST = aspartate aminotransferase; ALT = alanine 
aminotransferase.  
    †     Chi-square test or Fisher’s exact test or Mann-Whitney test were used as appropriate.   
    ‡     No. of patients with and without chronic HBV co-infection in critical period are 62 and 
498, respectively.   
    §     No. of patients with and without chronic HBV co-infection in convalescent period are 56 
and 417, respectively.   779 LIVER INVOLVEMENT IN ADULTS WITH DENGUE
might be expected to contribute to derangements in hemo-
static parameters, we only found prolonged PT values in the 
patients with liver failure. In most other patients, PT values 
fell within the normal range and were similar to the values seen 
in the OFI group. We also demonstrated only a weak correla-
tion between PT and transaminase levels during the convales-
cent period, suggesting that liver synthetic function in terms 
of coagulation factor production was generally well compen-
sated. We did find evidence of the typical dengue-associated 
coagulopathy of increased APTT and low fibrinogen levels in 
most patients, but low thrombocyte counts and dysfunction 
of the remaining thrombocytes are probably the major cause 
of clinical bleeding. Preliminary comparisons suggest that the 
thrombocytopenia is more severe in adults than in children, 
although formal assessment will be necessary to address this 
question properly. 
  The pathogenesis of liver involvement during dengue infec-
tions is still poorly understood.  31   Potential mechanisms of 
hepatic injury involve a variety of potential insults includ-
ing direct effects of the virus or host immune response on 
liver cells, circulatory compromise and/or hypoxia caused by 
hypotension or localized vascular leakage inside the liver cap-
sule, hepatotoxic effects of drugs such as acetaminophen or 
traditional herbal remedies, and tissue tropism of particular 
viral serotypes or genotypes. Given the fact that many organ 
systems are deranged by the time a patient dies, histopatho-
logic findings from autopsy studies are of limited value in 
attempting to clarify primary disease mechanisms, and unfor-
tunately suitable biopsy material is rarely available from less 
severe cases. The magnitude and evolution of the liver enzyme 
changes demonstrated in this study and the relationships that 
we observed with other markers of disease severity favor an 
adverse effect of immune dysregulation over a direct viral 
effect as the likely primary mechanism responsible for the 
hepatic dysfunction in the most patients. Dengue virus is rap-
idly cleared from plasma during the first few days of symp-
toms and viral RNA is rarely detectable after the first week of 
illness.  32   A direct viral effect might be expected to be maximal 
early in the infection coinciding with peak viremia, although it 
is plausible that virus remains sequestered in the liver for some 
time after clearance from plasma. However, the host immune 
response is well established by the time the critical phase (day 
4–6 of illness) is reached, particularly in secondary infections. 
There is a body of evidence supporting the view that compli-
cations such as shock and thrombocytopenia are primarily 
immune mediated, potentially involving a complex interaction 
between cytokines, activated T cells in tissues, immune com-
plexes, and other immune effector mechanisms.  2,  33  
  Regarding the effects of concomitant infection with other 
hepatitis viruses common in Asia, we found a significant 
increase in ALT levels in dengue patients with chronic HBV 
infection compared with those without infection. However, 
the effect was minor and did not affect coagulation param-
eters, bleeding severity, or clinical signs of liver disease. In 
the past, several small studies have shown no effect of HBV 
infection on acute dengue morbidity,  14,  15   but our findings are 
in agreement with a recent study in which nearly 400 patients 
with dengue-1 virus infection were studied and showed slightly 
greater increases in ALT levels among patients with HBV co-
infection.  23   We found no clinically significant effects in our 
study, but the possibility that repeated dengue infections may 
alter the rate of progression of the HBV infection needs to be 
considered. Few patients with HCV infection were identified 
and we were unable to assess the effects of co-infection with 
this virus. 
  In summary, among nearly 650 adults with dengue recruited 
over two years at one institution, liver involvement demon-
strated by increases in transaminase levels occurred in almost 
all patients and correlated with disease severity in terms of 
vascular leakage and bleeding. Jaundice and acute liver failure 
developed in only a small proportion of patients and occurred 
relatively late in the disease course, usually without evidence 
of vascular leakage severe enough to cause shock. Severe 
bleeding was more frequent, but also occurred commonly in 
the absence of major vascular leakage. The pathogenesis of 
liver involvement is still unknown but likely represents an 
adverse effect of the host immune response that is propor-
tional to the initial viral burden. In most patients, the effect 
is mild and full recovery is usual with supportive care. In the 
rare cases in which severe liver disease develops, additional 
mechanisms are probably involved but given the small num-
ber of cases, it is likely to prove difficult to identify the factors 
contributing to such idiosyncratic responses. 
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